Physician profile
Tara Bell
NPI 1487909826
$1,022.07
in general payments reported to CMS, 2019-2025
9 companies · $24.99 in 2025
The $24.99 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.52 · 2022: $230 · 2023: $469 · 2024: $270 · 2025: $24.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $764.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $632.46 | 2022-2025 | |
| Janssen Biotech, INC. | $157.22 | 2022-2024 | Stelara, Tremfya |
| Astrazeneca Pharmaceuticals Lp | $79.75 | 2022-2023 | Saphnelo |
| Horizon Therapeutics Plc | $41.50 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.93 | 2023 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $26.35 | 2023 | Dupixent |
| Amgen INC. | $24.60 | 2023 | Avsola |
| Insmed, INC. | $16.24 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.